Methotrexate is an immunosuppressive drug used to treat rheumatoid, psoriatic and juvenile idiopathic arthritis and vasculitis, said Dr. Mehret Birru Talabi, assistant professor of medicine at the ...

Researchers at the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have found that ...

Methotrexate is a strong drug that could help clear up your psoriasis.It’s part of a class of medications called antimetabolites that stop cells from dividing and slow their growth. In psoriasis ...

Methotrexate is a disease-modifying antirheumatic drug (DMARD) that may reduce pain and swelling. By slowing down disease progression, methotrexate may work to prevent joint damage too.

Methotrexate is a proven and efficacious therapy for inflammatory diseases such as rheumatoid arthritis. The main mechanism of action of methotrexate as an anti-cancer drug, at high doses ...

How Abortion Bans Are Affecting Access to Methotrexate, a Crucial Treatment for Autoimmune Disease. The medication is typically used to treat chronic illnesses like rheumatoid arthritis and lupus ...

Subcutaneous tocilizumab, either as monotherapy or combined with methotrexate, may benefit patients with active rheumatoid arthritis who have had an inadequate response to csDMARDs.

We'll be blunt: methotrexate flopped in a randomized placebo-controlled trial among patients with osteoarthritis (OA) of the knee. Contrary to results from a previous trial in hand OA, the old ...

Methotrexate helped her psoriasis clear up, reduced her joint pain, and allowed her to resume her life. She’d never had a problem having the prescription filled until after the Dobbs decision.

Researchers found that methotrexate was as effective in controlling the disease, with potentially fewer side effects than prednisone. The randomized, controlled trial, conducted as part of a ...

Researchers found that methotrexate was as effective in controlling the disease, with potentially fewer side effects than prednisone. The randomized, controlled trial, ...

Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, ...